ClinVar Miner

Submissions for variant NM_020631.6(PLEKHG5):c.1783G>C (p.Glu595Gln)

gnomAD frequency: 0.00019  dbSNP: rs140597591
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000658112 SCV000779883 uncertain significance not provided 2018-05-09 criteria provided, single submitter clinical testing The E595Q variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The E595Q variant is observed in 15/24014 (0.06%) alleles from individuals of African background in large population cohorts (Lek et al., 2016). The E595Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Invitae RCV000692019 SCV000819824 uncertain significance Neuronopathy, distal hereditary motor, autosomal recessive 4; Charcot-Marie-Tooth disease recessive intermediate C 2022-07-12 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 595 of the PLEKHG5 protein (p.Glu595Gln). This variant is present in population databases (rs140597591, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with PLEKHG5-related conditions. ClinVar contains an entry for this variant (Variation ID: 546263). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002397336 SCV002710383 uncertain significance Inborn genetic diseases 2022-01-11 criteria provided, single submitter clinical testing The p.E595Q variant (also known as c.1783G>C), located in coding exon 15 of the PLEKHG5 gene, results from a G to C substitution at nucleotide position 1783. The glutamic acid at codon 595 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.